Per Norlen
Chief Executive Officer Strike Pharma
Per has 20+ years in clinical drug dev in leading positions. He has previously been CEO of Alligator Bioscience, Targinta, Evaxion and WntResearch. He has also held roles as Chief Medical Officer of Alligator Bioscience and Xintela.
Seminars
Wednesday 10th February 2027
Affinity Conjugation to Enable Personalised & Targeted LNP Delivery for In Vivo CAR Therapy
2:15 pm
- Enabling attachment of personalised LNPs at the bedside
- Enhancing potency and efficacy of targeted LNPs to improve payload delivery and minimise off-target exposure
- Leveraging freeze-dried LNPs to simplify storage, distribution, and rapid bedside preparation
- Validated in mouse and NHP studies for both in vivo CAR-T and CAR-M
